533 related articles for article (PubMed ID: 9829574)
1. Cerebral glucose metabolism in patients with frontotemporal dementia.
Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
3. Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study.
Grimmer T; Diehl J; Drzezga A; Förstl H; Kurz A
Dement Geriatr Cogn Disord; 2004; 18(1):32-6. PubMed ID: 15084791
[TBL] [Abstract][Full Text] [Related]
4. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
Garraux G; Salmon E; Degueldre C; Lemaire C; Laureys S; Franck G
Neuroimage; 1999 Aug; 10(2):149-62. PubMed ID: 10417247
[TBL] [Abstract][Full Text] [Related]
5. Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study.
Diehl J; Grimmer T; Drzezga A; Riemenschneider M; Förstl H; Kurz A
Neurobiol Aging; 2004 Sep; 25(8):1051-6. PubMed ID: 15212830
[TBL] [Abstract][Full Text] [Related]
6. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
[TBL] [Abstract][Full Text] [Related]
8. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease.
Ishii K; Imamura T; Sasaki M; Yamaji S; Sakamoto S; Kitagaki H; Hashimoto M; Hirono N; Shimomura T; Mori E
Neurology; 1998 Jul; 51(1):125-30. PubMed ID: 9674790
[TBL] [Abstract][Full Text] [Related]
9. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
10. Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis.
Santens P; De Bleecker J; Goethals P; Strijckmans K; Lemahieu I; Slegers G; Dierckx R; De Reuck J
Eur Neurol; 2001; 45(1):19-27. PubMed ID: 11150836
[TBL] [Abstract][Full Text] [Related]
11. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study.
Meguro K; Yamaguchi S; Itoh M; Fujiwara T; Yamadori A
Neurology; 1997 Oct; 49(4):941-5. PubMed ID: 9339671
[TBL] [Abstract][Full Text] [Related]
13. FDG PET imaging in patients with pathologically verified dementia.
Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
[TBL] [Abstract][Full Text] [Related]
14. Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease.
Ibach B; Poljansky S; Marienhagen J; Sommer M; Männer P; Hajak G
Neuroimage; 2004 Oct; 23(2):739-43. PubMed ID: 15488423
[TBL] [Abstract][Full Text] [Related]
15. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E
J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143
[TBL] [Abstract][Full Text] [Related]
16. Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease.
Jeong Y; Park KC; Cho SS; Kim EJ; Kang SJ; Kim SE; Kang E; Na DL
Neurology; 2005 Feb; 64(4):734-6. PubMed ID: 15728305
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data.
Charpentier P; Lavenu I; Defebvre L; Duhamel A; Lecouffe P; Pasquier F; Steinling M
J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):661-3. PubMed ID: 11032624
[TBL] [Abstract][Full Text] [Related]
18. Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies.
Kanda T; Ishii K; Uemura T; Miyamoto N; Yoshikawa T; Kono AK; Mori E
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2227-34. PubMed ID: 18661129
[TBL] [Abstract][Full Text] [Related]
19. Medial temporal lobe metabolic impairment in dementia associated with motor neuron disease.
Garraux G; Salmon E; Degueldre C; Lemaire C; Franck G
J Neurol Sci; 1999 Oct; 168(2):145-50. PubMed ID: 10526199
[TBL] [Abstract][Full Text] [Related]
20. Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve.
Perneczky R; Diehl-Schmid J; Förstl H; Drzezga A; Kurz A
Int J Geriatr Psychiatry; 2007 Nov; 22(11):1135-40. PubMed ID: 17479980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
